Picard Medical, Inc. (PMI)
NYSEAMERICAN: PMI · Real-Time Price · USD
1.160
+0.080 (7.41%)
At close: Mar 9, 2026, 4:00 PM EDT
1.087
-0.073 (-6.32%)
After-hours: Mar 9, 2026, 6:33 PM EDT
Company Description
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products.
The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.
The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona.
Picard Medical, Inc. is a subsidiary of Hunniwell Picard I, Llc.
Picard Medical, Inc.
| Country | United States |
| Founded | 1981 |
| IPO Date | Aug 29, 2025 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 75 |
| CEO | Patrick Schnegelsberg |
Contact Details
Address: 1992 East Silverlake Road Tucson, Arizona 85713 United States | |
| Phone | 520-545-1234 |
| Website | picardmedical.com |
Stock Details
| Ticker Symbol | PMI |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0002030617 |
| CUSIP Number | 71953R108 |
| ISIN Number | US71953R1086 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Patrick N. J. Schnegelsberg | Chief Executive Officer and Director |
| Bernard Skaggs | Chief Financial Officer |
| Matthew Schuster | Chief Operating Officer |
| Dr. Frank Tinker Ph.D. | Chief Technology Officer of SynCardia Systems, LLC |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 2, 2026 | 8-K | Current Report |
| Feb 26, 2026 | 8-K | Current Report |
| Feb 19, 2026 | DEFR14A | Filing |
| Feb 19, 2026 | DEF 14A | Other definitive proxy statements |
| Feb 11, 2026 | SCHEDULE 13G | Filing |
| Feb 10, 2026 | PRE 14A | Other preliminary proxy statements |
| Feb 10, 2026 | 424B3 | Prospectus |
| Feb 6, 2026 | EFFECT | Notice of Effectiveness |
| Feb 4, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jan 27, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |